Cargando…

Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program

OBJECTIVE: To determine the prevalence of obesity and metabolic syndrome (MetS) in children and adolescents with type 1 diabetes (T1D) and to compare the widely accepted and used diagnostic criteria for MetS established by the International Diabetes Federation (IDF), World Health Organisation (WHO)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yayıcı Köken, Özlem, Kara, Cengiz, Can Yılmaz, Gülay, Aydın, Hasan Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127892/
https://www.ncbi.nlm.nih.gov/pubmed/31434460
http://dx.doi.org/10.4274/jcrpe.galenos.2019.2019.0048
_version_ 1783516459664670720
author Yayıcı Köken, Özlem
Kara, Cengiz
Can Yılmaz, Gülay
Aydın, Hasan Murat
author_facet Yayıcı Köken, Özlem
Kara, Cengiz
Can Yılmaz, Gülay
Aydın, Hasan Murat
author_sort Yayıcı Köken, Özlem
collection PubMed
description OBJECTIVE: To determine the prevalence of obesity and metabolic syndrome (MetS) in children and adolescents with type 1 diabetes (T1D) and to compare the widely accepted and used diagnostic criteria for MetS established by the International Diabetes Federation (IDF), World Health Organisation (WHO) and National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII). METHODS: We conducted a descriptive, cross sectional study including T1D patients between 8-18 years of age. The three sets of criteria were used to determine the prevalence of MetS and findings compared. Risk factors related to MetS were extracted from hospital records. RESULTS: The study included 200 patients with T1D (52% boys). Of these, 18% (n=36) were overweight/obese (body mass index percentile ≥85%). MetS prevalence was 10.5%, 8.5% and 13.5% according to IDF, WHO and NCEP criteria, respectively. There were no statistically significant differences in age, gender, family history of T1D and T2D, pubertal stage, duration of diabetes, hemoglobin A1c levels and daily insulin doses between patients with or without MetS. In the overweight or obese T1D patients, the prevalence of MetS was 44.4%, 38.8% and 44.4% according to IDF, WHO and NCEP-ATPIII criteria, respectively. CONCLUSION: Obesity prevalence in the T1D cohort was similar to that of the healthy population of the same age. Prevalence of MetS was higher in children and adolescents with T1D compared to the obese population in Turkey. The WHO criteria include microvascular complications which are rare in childhood and the NCEP criteria do not include a primary criterion while diagnosing non-obese patients according to waist circumference as MetS because the existence of diabetes is considered as a direct criterion. Our study suggests that IDF criteria which allows the diagnosis of MetS with obesity and have accepted criteria for the childhood are more suitable for the diagnosis of MetS in children and adolescents with T1D.
format Online
Article
Text
id pubmed-7127892
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-71278922020-04-13 Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program Yayıcı Köken, Özlem Kara, Cengiz Can Yılmaz, Gülay Aydın, Hasan Murat J Clin Res Pediatr Endocrinol Original Article OBJECTIVE: To determine the prevalence of obesity and metabolic syndrome (MetS) in children and adolescents with type 1 diabetes (T1D) and to compare the widely accepted and used diagnostic criteria for MetS established by the International Diabetes Federation (IDF), World Health Organisation (WHO) and National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII). METHODS: We conducted a descriptive, cross sectional study including T1D patients between 8-18 years of age. The three sets of criteria were used to determine the prevalence of MetS and findings compared. Risk factors related to MetS were extracted from hospital records. RESULTS: The study included 200 patients with T1D (52% boys). Of these, 18% (n=36) were overweight/obese (body mass index percentile ≥85%). MetS prevalence was 10.5%, 8.5% and 13.5% according to IDF, WHO and NCEP criteria, respectively. There were no statistically significant differences in age, gender, family history of T1D and T2D, pubertal stage, duration of diabetes, hemoglobin A1c levels and daily insulin doses between patients with or without MetS. In the overweight or obese T1D patients, the prevalence of MetS was 44.4%, 38.8% and 44.4% according to IDF, WHO and NCEP-ATPIII criteria, respectively. CONCLUSION: Obesity prevalence in the T1D cohort was similar to that of the healthy population of the same age. Prevalence of MetS was higher in children and adolescents with T1D compared to the obese population in Turkey. The WHO criteria include microvascular complications which are rare in childhood and the NCEP criteria do not include a primary criterion while diagnosing non-obese patients according to waist circumference as MetS because the existence of diabetes is considered as a direct criterion. Our study suggests that IDF criteria which allows the diagnosis of MetS with obesity and have accepted criteria for the childhood are more suitable for the diagnosis of MetS in children and adolescents with T1D. Galenos Publishing 2020-03 2020-03-19 /pmc/articles/PMC7127892/ /pubmed/31434460 http://dx.doi.org/10.4274/jcrpe.galenos.2019.2019.0048 Text en ©Copyright 2020 by Turkish Pediatric Endocrinology and Diabetes Society | The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yayıcı Köken, Özlem
Kara, Cengiz
Can Yılmaz, Gülay
Aydın, Hasan Murat
Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program
title Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program
title_full Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program
title_fullStr Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program
title_full_unstemmed Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program
title_short Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program
title_sort prevalence of obesity and metabolic syndrome in children with type 1 diabetes: a comparative assessment based on criteria established by the international diabetes federation, world health organisation and national cholesterol education program
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127892/
https://www.ncbi.nlm.nih.gov/pubmed/31434460
http://dx.doi.org/10.4274/jcrpe.galenos.2019.2019.0048
work_keys_str_mv AT yayıcıkokenozlem prevalenceofobesityandmetabolicsyndromeinchildrenwithtype1diabetesacomparativeassessmentbasedoncriteriaestablishedbytheinternationaldiabetesfederationworldhealthorganisationandnationalcholesteroleducationprogram
AT karacengiz prevalenceofobesityandmetabolicsyndromeinchildrenwithtype1diabetesacomparativeassessmentbasedoncriteriaestablishedbytheinternationaldiabetesfederationworldhealthorganisationandnationalcholesteroleducationprogram
AT canyılmazgulay prevalenceofobesityandmetabolicsyndromeinchildrenwithtype1diabetesacomparativeassessmentbasedoncriteriaestablishedbytheinternationaldiabetesfederationworldhealthorganisationandnationalcholesteroleducationprogram
AT aydınhasanmurat prevalenceofobesityandmetabolicsyndromeinchildrenwithtype1diabetesacomparativeassessmentbasedoncriteriaestablishedbytheinternationaldiabetesfederationworldhealthorganisationandnationalcholesteroleducationprogram